Seres Therapeutics, Inc. 8-K Filing
Ticker: MCRB · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1609809
| Field | Detail |
|---|---|
| Company | Seres Therapeutics, Inc. (MCRB) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Seres Therapeutics, Inc. (ticker: MCRB) to the SEC on Jan 13, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ich registered Common stock, par value $0.001 per share MCRB The Nasdaq Stock Mar).
How long is this filing?
Seres Therapeutics, Inc.'s 8-K filing is 2 pages with approximately 570 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 570 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2025-01-13 08:06:36
Key Financial Figures
- $0.001 — ich registered Common stock, par value $0.001 per share MCRB The Nasdaq Stock Mar
Filing Documents
- d923845d8k.htm (8-K) — 26KB
- d923845dex991.htm (EX-99.1) — 44KB
- g923845ex99_1p10g1.jpg (GRAPHIC) — 381KB
- g923845ex99_1p11g1.jpg (GRAPHIC) — 335KB
- g923845ex99_1p12g1.jpg (GRAPHIC) — 215KB
- g923845ex99_1p13g1.jpg (GRAPHIC) — 288KB
- g923845ex99_1p14g1.jpg (GRAPHIC) — 324KB
- g923845ex99_1p15g1.jpg (GRAPHIC) — 188KB
- g923845ex99_1p16g1.jpg (GRAPHIC) — 328KB
- g923845ex99_1p17g1.jpg (GRAPHIC) — 215KB
- g923845ex99_1p18g1.jpg (GRAPHIC) — 225KB
- g923845ex99_1p19g1.jpg (GRAPHIC) — 205KB
- g923845ex99_1p1g1.jpg (GRAPHIC) — 259KB
- g923845ex99_1p20g1.jpg (GRAPHIC) — 226KB
- g923845ex99_1p21g1.jpg (GRAPHIC) — 249KB
- g923845ex99_1p22g1.jpg (GRAPHIC) — 275KB
- g923845ex99_1p23g1.jpg (GRAPHIC) — 309KB
- g923845ex99_1p24g1.jpg (GRAPHIC) — 300KB
- g923845ex99_1p25g1.jpg (GRAPHIC) — 342KB
- g923845ex99_1p26g1.jpg (GRAPHIC) — 337KB
- g923845ex99_1p27g1.jpg (GRAPHIC) — 207KB
- g923845ex99_1p28g1.jpg (GRAPHIC) — 289KB
- g923845ex99_1p29g1.jpg (GRAPHIC) — 241KB
- g923845ex99_1p2g1.jpg (GRAPHIC) — 662KB
- g923845ex99_1p30g1.jpg (GRAPHIC) — 287KB
- g923845ex99_1p31g1.jpg (GRAPHIC) — 274KB
- g923845ex99_1p32g1.jpg (GRAPHIC) — 269KB
- g923845ex99_1p33g1.jpg (GRAPHIC) — 364KB
- g923845ex99_1p34g1.jpg (GRAPHIC) — 374KB
- g923845ex99_1p3g1.jpg (GRAPHIC) — 507KB
- g923845ex99_1p4g1.jpg (GRAPHIC) — 332KB
- g923845ex99_1p5g1.jpg (GRAPHIC) — 368KB
- g923845ex99_1p6g1.jpg (GRAPHIC) — 261KB
- g923845ex99_1p7g1.jpg (GRAPHIC) — 299KB
- g923845ex99_1p8g1.jpg (GRAPHIC) — 240KB
- g923845ex99_1p9g1.jpg (GRAPHIC) — 291KB
- 0001193125-25-005011.txt ( ) — 14345KB
- mcrb-20250113.xsd (EX-101.SCH) — 3KB
- mcrb-20250113_lab.xml (EX-101.LAB) — 17KB
- mcrb-20250113_pre.xml (EX-101.PRE) — 11KB
- d923845d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. The following Exhibit 99.1 relates to Item 7.01 and shall be deemed to be furnished, and not filed: Exhibit No. Description 99.1 Seres Therapeutics, Inc. Corporate Presentation as of January 2025 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 13, 2025 SERES THERAPEUTICS, INC. By: /s/ Thomas J. DesRosier Name: Thomas J. DesRosier Title: Chief Legal Officer and Executive Vice President